From: Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
Clinicopathological Characteristics | Value (%) |
---|---|
Median age (years) | 60.0 (range, 35–82 years) |
Gender | |
Male | 62 (58.5%) |
Female | 44 (41.5%) |
HBV infection | |
Absent | 64 (60.4%) |
Present | 42 (39.6%) |
Preoperative AFP (μg/l) | |
< 9 | 78 (73.6%) |
≥ 9 | 28 (26.4%) |
Preoperative CA19–9 (U/ml) | |
< 35 | 33 (31.1%) |
≥ 35 | 73 (68.9%) |
Tumor size (mm) | |
< 50 | 45 (42.5%) |
≥ 50 | 61 (57.5%) |
Tumor number | |
Single | 89 (84.0%) |
Multiple | 17 (16.0%) |
Vascular invasion | |
Absent | 78 (73.6%) |
Present | 28 (26.4%) |
Lymph node metastasis | |
Absent | 58 (54.7%) |
Present | 48 (45.3%) |
Histologic differentiation | |
Well or moderate | 52 (49.1%) |
Poor | 54 (50.9%) |
Distribution | |
Unilobar | 41 (38.7%) |
Bilobar | 65 (61.3%) |
Perineural sheath infiltration | |
Absent | 92 (86.8%) |
Present | 14 (13.2%) |
TNM stage | |
I | 33 (31.1%) |
II | 15 (14.2%) |
III | 10 (9.4%) |
IV | 48 (45.3%) |
Tumor recurrence | |
Absent | 34 (32.1%) |
Present | 72 (67.9%) |